Kimberly R Lockett

Array ( [id] => 6796998 [patent_doc_number] => 20030175872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/152390 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63478 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175872.pdf [firstpage_image] =>[orig_patent_app_number] => 10152390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651304 [patent_doc_number] => 20030105047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Techniques for treating neurodegenerative disorders by brain infusion of mutational vectors' [patent_app_type] => new [patent_app_number] => 10/133957 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7752 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105047.pdf [firstpage_image] =>[orig_patent_app_number] => 10133957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865225 [patent_doc_number] => 20030190751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Directed switch-mediated DNA recombination' [patent_app_type] => new [patent_app_number] => 10/115668 [patent_app_country] => US [patent_app_date] => 2002-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12249 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190751.pdf [firstpage_image] =>[orig_patent_app_number] => 10115668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7425291 [patent_doc_number] => 20040161416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Systemic gene treatment of connective tissue diseases' [patent_app_type] => new [patent_app_number] => 10/086068 [patent_app_country] => US [patent_app_date] => 2002-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15083 [patent_no_of_claims] => 142 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161416.pdf [firstpage_image] =>[orig_patent_app_number] => 10086068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 509159 [patent_doc_number] => 07195911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-27 [patent_title] => 'Mammalian cells that have increased proliferative capacity' [patent_app_type] => utility [patent_app_number] => 10/044539 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 40 [patent_no_of_words] => 64736 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/195/07195911.pdf [firstpage_image] =>[orig_patent_app_number] => 10044539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7085200 [patent_doc_number] => 20050050580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Transgenic animal expressing hla-a24 and utilization thereof' [patent_app_type] => utility [patent_app_number] => 10/450255 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16800 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20050050580.pdf [firstpage_image] =>[orig_patent_app_number] => 10450255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715974 [patent_doc_number] => 20030027322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Helper virus-free herpesvirus amplicon particles and uses thereof' [patent_app_type] => new [patent_app_number] => 09/997848 [patent_app_country] => US [patent_app_date] => 2001-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17573 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027322.pdf [firstpage_image] =>[orig_patent_app_number] => 09997848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829194 [patent_doc_number] => 20020068715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'DNA vaccination for treatment of autoimmune disease' [patent_app_type] => new [patent_app_number] => 09/947770 [patent_app_country] => US [patent_app_date] => 2001-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16422 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068715.pdf [firstpage_image] =>[orig_patent_app_number] => 09947770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 659106 [patent_doc_number] => 07105717 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-12 [patent_title] => 'Model rat with the onset of prostatic cancer' [patent_app_type] => utility [patent_app_number] => 10/204504 [patent_app_country] => US [patent_app_date] => 2000-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5491 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105717.pdf [firstpage_image] =>[orig_patent_app_number] => 10204504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 687189 [patent_doc_number] => 07078500 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-18 [patent_title] => 'Genetic immunization with nonstructural proteins of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 09/600493 [patent_app_country] => US [patent_app_date] => 1999-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 8669 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078500.pdf [firstpage_image] =>[orig_patent_app_number] => 09600493 [rel_patent_id] =>[rel_patent_doc_number] =>)